Answers are grounded in this paper and cite their sources.
Diabetic retinopathy may cause practical blindness in both the proliferative and the back- ground stages of the disease.In the latter, visual impairment is caused by a direct affec- tion of the macular area, a condition to which the term diabetic maculopathy is often applied.Diabetic maculopathy is composed of two basic types of lesion: lipoid deposits and foci of pathological capillaries (Dobree, I970).Lipoid deposits may appear as clusters of hard exudates, large and small rings (circinate retinopathy), or plaques of lipoid material (King, Dobree, Kok, Foulds, and Dangerfield, I963).In addition to the lipoid deposits, macular oedema can be seen.It has been suggested (Gass, I968; Maumenee, I968) that lipoid deposits, in any form, result from leakage from the diseased capillaries.Systemic treatment by drugs or local treatment by photocoagulation have been suggested.Drugs to enhance the absorption of the deposits have been used (Caird, Pirie, and Ramsell, I969), but the visual results were doubtful.Recently, Xenon-arc photocoagulation has been recommended by several authors.Welch (I969) and Spalter (I97I) photocoagulated the centres of circinate formations, and claimed remarkable success in improving vision in some cases.Rubinstein and Myska (I972) treated diabetic maculopathy by Xenon-arc photocoagulation of leaking capillaries either at the centre of ring formations or elsewhere, or by perimacular (around the macula) or paramacular (temporally to the macular area) "bombing".Xenon-arc photocoagulation of diabetic maculopathy has also been used by Gass (I97i) and by Krill, Archer, Newell, and Chishti (I97I).The use of argon-laser photocoagulation has recently been suggested.Patz (I972) and Patz, Maumenee, and Ryan (I971) advised that it should be used to treat mainly intra- retinal microvascular abnormalities (IRMA) in the paramacular area.Zweng, Little, and Peabody (1972) treated 35 eyes with diabetic maculopathy and claimed visual improve- ment in 71 per cent.Behrendt (I972) treated six cases of diabetic maculopathy by partial occlusion of the small arterioles approaching the macula and claimed visual improvement in all.It is the purpose of this paper to describe our experience with argon-laser treatment of diabetic maculopathy.The results were evaluated in each case by visual acuity and fluorescein angiography.
No takes yet. Share an insight, caveat, or question.
Merin et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: